drugset / Trial / NCT02462681

Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery

NCT02462681

Phase 1/2 Completed 90 enrolled Assiut University
RandomizedCrossoverDouble-blindTreatment

Summary

This study aims to investigate the safety and the analgesic efficacy of adding Ketamine to bupivacaine 0.25% in thoracic PVB in patients undergoing modified radical mastectomy.

Timeline

Start
2015-05
Primary completion
2016-12
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.5 mg/kg Other
Comparator Ketamine Small molecule 1 mg/kg Other
Comparator Bupivacaine Other / unclassified 0.25 % Other
Comparator Bupivacaine Other / unclassified 20 ml Other
Comparator Lidocaine Other / unclassified Other

Indications